Name
GS2-04 - Aromatase inhibitors versus tamoxifen in pre-menopausal women with ER+ early stage breast cancer treated with ovarian suppression: A patient level meta-analysis of 7,030 women in four randomised trials
Date & Time
Tuesday, December 7, 2021
Adam Brufsky, MD, PhD
Virtual Session Link